drugset / Trial / NCT00206765

Risperidone vs. Paroxetine for Panic Attacks

NCT00206765

Phase 2 Terminated 90 enrolled Beth Israel Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

We are comparing the efficacy of Risperidone versus Paroxetine in the treatment of panic symptoms. The study hypothesis is that Risperidone will be a superior medicine for treating panic.

Timeline

Start
2003-01
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 5 mg Oral
Subject Paroxetine Small molecule 10 mg Oral
Subject Paroxetine Small molecule 20 mg Oral
Subject Paroxetine Small molecule 30 mg Oral
Subject Paroxetine Small molecule 40 mg Oral
Subject Risperidone Other / unclassified 0.125 mg Oral
Subject Risperidone Other / unclassified 0.25 mg Oral
Subject Risperidone Other / unclassified 0.5 mg Oral